^
    Back
    Association details:
    Biomarker:FGFR2 M540_I541insMM
    Cancer:Cholangiocarcinoma
    Drug:Pemazyre (pemigatinib) (FGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    Target Oncol
    Title:

    Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

    Published date:
    09/02/2022
    Excerpt:
    In addition, one patient treated with pemigatinib developed FGFR2 M540_I541insMM alteration at time of resistance…
    DOI:
    10.1007/s11523-022-00914-w